---

Wernicke's Encephalopathy & Korsakoff's Psychosis: A Complete Guide

1. Overview & Historical Context

• WE was first described by Gayet (French ophthalmologist) in 1875, and independently by Carl Wernicke (German neurologist) in 1881.
• "Korsakoff psychosis" is an older term; modern neurology prefers Korsakoff syndrome or amnesic state, as psychosis is not the dominant feature. — Adams and Victor's Principles of Neurology, 12th ed.

---

2. Thiamine Biochemistry & Pathophysiology

• Pyruvate dehydrogenase — entry into the TCA cycle
• α-ketoglutarate dehydrogenase — TCA cycle intermediate step
• Transketolase — pentose phosphate pathway

---

3. Causes & Risk Factors

Primary Cause

• Chronic alcohol use disorder — the most common cause in Western countries (both reduced dietary intake and impaired intestinal absorption)

Non-alcoholic Causes

Risk Factors in Alcohol Dependence (Maudsley Guidelines)

• Acute withdrawal
• Malnourishment / low BMI (<18)
• Decompensated liver disease
• Emergency department attendance or acute hospitalization
• Homelessness
• Memory disturbance or peripheral neuropathy
• Previous episode of WE

---

4. Neuropathology

Affected Brain Regions

• Mammillary bodies (most characteristic; bilaterally affected)
• Periaqueductal gray matter
• Medial thalami (anterior and centromedian nuclei; dorsomedial thalamic nucleus lesions best correlate with memory disturbance in KS)
• Floor of the fourth ventricle
• Superior and inferior colliculi
• Hypothalamus (occasionally)
• Cerebral cortex (rarely, in severe cases)

Microscopic Changes

• Neuronal swelling and microscopic hemorrhages (early)
• Gliosis (later)
• Resolution of necrosis → cystic spaces with hemosiderin-laden macrophages

---

5. Clinical Presentation

Wernicke's Encephalopathy: Classic Triad

⚠️ The full triad is present in only ~30% of cases. Up to 75% of cases are undiagnosed at the time of death (only ~25% detected before death). — Goldman-Cecil Medicine

Additional Features

• Autonomic dysfunction: bradycardia, hypothermia, hypotension (can be life-threatening)
• Papilledema, optic neuropathy
• Seizures, myoclonus
• Peripheral neuropathy
• Signs of chronic alcoholism (gynecomastia, palmar erythema, Dupuytren's contractures, ascites)

Maudsley Guidance: Presume WE in Any Detoxification Patient with ANY of:

• Ataxia
• Hypothermia or hypotension
• Confusion or memory disturbance
• Ophthalmoplegia / nystagmus
• Unconsciousness / coma

---

6. Korsakoff's Syndrome

Core Features

1. Retrograde amnesia — impaired recall of events established before onset
2. Anterograde amnesia — inability to form new memories or learn new information
3. Impaired temporal localization of past experience

What Is Preserved

• Alertness and attention
• Language comprehension and expression
• Spatial organization
• Procedural (motor) memory
• Immediate recall (digit span) — a measure of registration/attention, not memory encoding
• Social interaction

"Equally important in the definition of the Korsakoff syndrome is this integrity of certain aspects of behavior and mental function." — Adams & Victor's Principles of Neurology

Confabulation

• Momentary confabulation: partial memories inaccurately localized in time, provoked by questions
• Fantastic confabulation: spontaneous elaborate false narratives; more common in the initial confused phase
• Confabulation is not obligate for diagnosis; it typically lessens over time as a compensatory mechanism — Adams & Victor

Neuropsychological Profile

• Anterograde > retrograde amnesia severity
• Remote (early life) memories relatively preserved vs. recent (Ribot's Rule)
• Mild executive dysfunction (frontal lobe involvement)
• Patients are typically unaware of their memory impairment (anosognosia)

---

7. Neuroimaging

MRI Findings in Acute WE

• Mammillary bodies
• Periaqueductal gray matter
• Medial thalami / periventricular regions of the 3rd ventricle
• Floor of the 4th ventricle / pons / medulla
• Basal ganglia (less commonly)
• Cortex (rare; implies severe disease)

Special MRI Findings

• DWI: restricted diffusion (cytotoxic edema); may show vasogenic component (increased ADC)
• Microbleeds on T1/GRE in thalami and mammillary bodies → poor outcome marker
• Contrast enhancement of mammillary bodies: present in ~80% of cases, even before T2 changes are visible — considered highly specific — Grainger & Allison's Diagnostic Radiology
• Periaqueductal contrast enhancement: ~50% of cases

MRI in Chronic Korsakoff Syndrome

• T2 signal changes become less prominent
• Diffuse brain atrophy, most pronounced in the mesencephalon and mammillary bodies

MRI can be normal in symptomatic WE — a normal MRI does not exclude the diagnosis.

---

8. Laboratory Investigations

---

9. Diagnosis

1. Dietary deficiency
2. Oculomotor abnormalities
3. Cerebellar dysfunction
4. Either altered mental status or mild memory impairment

Differential Diagnoses to Consider

• Hepatic encephalopathy
• Delirium tremens (overlapping with acute alcohol withdrawal)
• Meningitis/encephalitis
• Posterior reversible encephalopathy syndrome (PRES)
• Central pontine myelinolysis
• Drug intoxication / overdose
• Stroke (thalamic, brainstem)

---

10. Treatment

Principle: Treat First, Confirm Later

"In acute settings, especially in ICUs, all patients should receive replenishment with high-dose IV or IM thiamine prior to any glucose administration." — Goldman-Cecil Medicine

Thiamine Replacement Doses

• IV or IM thiamine 500–1000 mg/day × 3–5 days — Goldman-Cecil Medicine
• UK NICE / Maudsley Guidelines: IV thiamine (Pabrinex) 2–3 pairs (each pair = 250 mg) three times daily for 3–5 days

• Community: IM thiamine 200–300 mg once daily for at least 3 days
• Hospital: IM or IV thiamine 200–300 mg once daily for 3–5 days with daily monitoring

• Oral thiamine 300 mg daily during withdrawal

Additional Measures

• Never give IV glucose before thiamine in a thiamine-deficient or at-risk patient
• Replace magnesium (required cofactor for thiamine-dependent enzymes)
• Replace sodium if deficient
• Monitor electrolytes, fluid balance
• Treat nausea/vomiting (metoclopramide 10 mg or prochlorperazine 5 mg)

Response to Treatment

• Nystagmus and ophthalmoplegia resolve first — often within hours of thiamine administration
• Ataxia resolves more slowly (days to weeks)
• Mental status changes — variable; may partially or fully resolve
• Korsakoff syndrome does not respond to thiamine replacement — prevention by early recognition of WE is essential

---

11. Prevention

• Thiamine supplementation of anyone at risk due to vomiting, starvation, bariatric surgery, dialysis, or malnutrition (>100 mg/day)
• Routine thiamine fortification of foods (e.g., flour, rice) has reduced the population burden
• Universal thiamine before IV dextrose in the emergency department for at-risk patients
• Post-bariatric surgery: lifelong thiamine supplementation is standard of care

---

12. Prognosis

"Because Korsakoff syndrome does not respond to thiamine replacement, prevention by timely recognition of Wernicke encephalopathy is essential." — Goldman-Cecil Medicine

Recovery from KS

---

13. Special Populations

Pregnancy (Hyperemesis Gravidarum)

Bariatric Surgery

Renal Failure / Dialysis

HIV/AIDS & Cancer

---

14. Comparison: WE vs. KS

---

15. Key Takeaways for Clinical Practice

1. Diagnose clinically — do not wait for lab confirmation or MRI to start thiamine.
2. The full classic triad is present in <30% of cases — treat on suspicion.
3. Never administer IV glucose before thiamine in any malnourished or alcohol-dependent patient.
4. High-dose IV thiamine (500–1000 mg/day for 3–5 days) is the standard for suspected WE.
5. Magnesium replacement is mandatory alongside thiamine.
6. Korsakoff syndrome is preventable but not treatable — early WE recognition is the only strategy.
7. Non-alcoholic WE is common — think bariatric surgery, hyperemesis, cancer, dialysis.
8. Only 25% of WE cases are detected before death — the syndrome is massively under-recognized.

---

Sources

• Goldman-Cecil Medicine, International Edition
• Adams and Victor's Principles of Neurology, 12th Edition
• Maudsley Prescribing Guidelines in Psychiatry, 15th Edition
• Grainger & Allison's Diagnostic Radiology
• Robbins & Kumar Basic Pathology
• Bradley and Daroff's Neurology in Clinical Practice
• Recent systematic reviews: PMID 37322816 (WE in hyperemesis gravidarum, 2023), PMID 37838073 (WE in kidney disease, 2024), PMID 38306946 (diagnosis and treatment systematic review, 2024)